Perceptive Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-670,206
| Closed | -$68.3M | – | 104 |
|
|
2023
Q2 | $68.3M | Sell |
670,206
-1,499,070
| -69% | -$153M | 1.98% | 16 |
|
|
2023
Q1 | $197M | Buy |
+2,169,276
| New | +$197M | 5.82% | 2 |
|
|
2022
Q4 | – | Sell |
-100,000
| Closed | -$2.51M | – | 118 |
|
|
2022
Q3 | $2.51M | Buy |
+100,000
| New | +$2.51M | 0.07% | 97 |
|
|
2022
Q2 | – | Sell |
-44,475
| Closed | -$1.46M | – | 135 |
|
|
2022
Q1 | $1.46M | Buy |
+44,475
| New | +$1.46M | 0.03% | 122 |
|
|
2018
Q4 | – | Sell |
-9,677
| Closed | -$791K | – | 128 |
|
|
2018
Q3 | $791K | Buy |
+9,677
| New | +$791K | 0.02% | 95 |
|